TickerFactsScreenerDevelopers

Vistagen Therapeutics, Inc. (VTGN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$6.56M2012: -$9.04M2013: -$6.79M2014: -$5.03M2015: -$6.78M2016: -$17.85M2017: -$10.25M2018: -$14.20M2019: -$24.56M2020: -$20.80M2021: -$17.93M2022: -$47.78M2023: -$59.27M2024: -$33.02M2025: -$55.97M2026: -$72.13M-$72.13M
2011Operating Income (USD)2026
Fiscal YearOperating IncomeChange YoY
2026-$72.13M-28.9%
2025-$55.97M-69.5%
2024-$33.02M+44.3%
2023-$59.27M-24.0%
2022-$47.78M-166.4%
2021-$17.93M+13.8%
2020-$20.80M+15.3%
2019-$24.56M-72.9%
2018-$14.20M-38.6%
2017-$10.25M+42.6%
2016-$17.85M-163.4%
2015-$6.78M-34.8%
2014-$5.03M+26.0%
2013-$6.79M+24.9%
2012-$9.04M-37.8%
2011-$6.56M—